| 1 |
Teunissen, S. C., Wesker, W., Kruitwagen, C., de Haes, H. C., Voest, E. E. and de Graeff, A. 2007. Symptom prevalence in patients with incurable cancer: a systematic review. J. Pain Symptom Manage. 34, 94-104.
DOI
|
| 2 |
Tisdale, M. J. 2008. Catabolic mediators of cancer cachexia. Curr. Opin. Support. Palliat. Care 2, 256-261.
DOI
|
| 3 |
Tisdale, M. J. 2009. Mechanisms of cancer cachexia. Physiol. Rev. 89, 381-410.
DOI
|
| 4 |
Tsai, V. W., Husaini, Y., Manandhar, R., Lee-Ng, K. K., Zhang, H. P., Harriott, K., Jiang, L., Lin, S., Sainsbury, A., Brown, D. A. and Breit, S. N. 2012. Anorexia/cachexia of chronic diseases: a role for the TGF-beta family cytokine MIC-1/GDF15. J. Cachexia Sarcopenia Muscle 3, 239-243.
DOI
|
| 5 |
Coll, A. P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J. A., Cimino, I., Yang, M., Welsh, P., Virtue, S., Goldspink, D. A., Miedzybrodzka, E. L., Konopka, A. R., Esponda, R. R., Huang, J. T., Tung, Y. C. L., Rodriguez-Cuenca, S., Tomaz, R. A., Harding, H. P., Melvin, A., Yeo, G. S. H., Preiss, D., Vidal-Puig, A., Vallier, L., Nair, K. S., Wareham, N. J., Ron, D., Gribble, F. M., Reimann, F., Sattar, N., Savage, D. B., Allan, B. B. and O'Rahilly, S. 2020. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444-448.
DOI
|
| 6 |
Glass, D. J. 2010. Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 225-229.
DOI
|
| 7 |
Inui, A. 2002. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J. Clin. 52, 72-91.
DOI
|
| 8 |
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M. and Spiegelman, B. M. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839.
DOI
|
| 9 |
Huang, X., Huang, Z., Yang, J., Xu, Y., Sun, J., Zheng, Q., Wei, C., Song, W. and Yuan, Z. 2016. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. J. Exp. Clin. Cancer Res. 35, 46.
DOI
|
| 10 |
Inui, A. 2001. Cytokines and sickness behavior: implications from knockout animal models. Trends. Immunol. 22, 469-473.
DOI
|
| 11 |
Kir, S., Komaba, H., Garcia, A. P., Konstantinos, P. E., Wei, L., Beate, L., Richard, A. H. and Bruce, M. S. 2016. PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab. 23, 315-323.
DOI
|
| 12 |
Kir, S., White, J. P., Kleiner, S., Kazak, L., Cohen, P., Baracos, V. E. and Spiegelman, B. M. 2014. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513, 100-104.
DOI
|
| 13 |
Laviano, A., Inui, A., Marks, D. L., Meguid, M. M., Pichard, C., Rossi Fanelli, F. and Seelaender, M. 2008. Neural control of the anorexia-cachexia syndrome. Am. J. Physiol. Endocrinol. Metab. 295, E1000-1008.
|
| 14 |
Mantovani, G., Maccio, A., Mura, L., Massa, E., Mudu, M. C., Mulas, C., Lusso, M. R., Madeddu, C. and Dessi, A. 2000. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J. Mol. Med (Berl). 78, 554-561.
DOI
|
| 15 |
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., Davis, M., Muscaritoli, M., Ottery, F., Radbruch, L., Ravasco, P., Walsh, D., Wilcock, A., Kaasa, S. and Baracos, V. E. 2011. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489-495.
DOI
|
| 16 |
Siddiqui, R. A. and Williams, J. F. 1990. Tentative identification of the toxohormones of cancer cachexia: roles of vasopressin, prostaglandin E2 and cachectin-TNF. Biochem. Int. 20, 787-797.
|
| 17 |
Noguchi, Y., Yoshikawa, T., Matsumoto, A., Svaninger, G. and Gelin, J. 1996. Are cytokines possible mediators of cancer cachexia? Surg. Today 26, 467-475.
DOI
|
| 18 |
Patra, S. K. and Arora, S. 2012. Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome. Clin. Chim. Acta. 413, 1025-1034.
DOI
|
| 19 |
Wang, G., Zhang, H. and Lyden, D. 2021. Tumour-regulated anorexia preceding cachexia. Nat. Cell. Biol. 23, 111-113.
DOI
|
| 20 |
Warren, S. 1932. The immediate causes of death in cancer. Am. J. Med. Sci. 184, 610-615.
DOI
|
| 21 |
Argiles, J. M., Anker, S. D., Evans, W. J., Morley, J. E., Fearon, K. C., Strasser, F., Muscaritoli, M. and Baracos, V. E. 2010. Consensus on cachexia definitions. J. Am. Med. Dir. Assoc. 11, 229-230.
DOI
|
| 22 |
Wagner, E. F. and Petruzzelli, M. 2015. Cancer metabolism: A waste of insulin interference. Nature 521, 430-431.
DOI
|
| 23 |
Woods, S. C., Seeley, R. J., Porte Jr, D. and Schwartz, M. W. 1998. Signals that regulate food intake and energy homeostasis. Science 280, 1378-1383.
DOI
|
| 24 |
Amitani, M., Asakawa, A., Amitani, H. and Inui, A. 2013. Control of food intake and muscle wasting in cachexia. Int. J. Biochem. Cell. Biol. 45, 2179-2185.
DOI
|
| 25 |
Argiles, J. M., Busquets, S., Toledo, M. and Lopez-Soriano, F. J. 2009. The role of cytokines in cancer cachexia. Curr. Opin. Support Palliat. Care. 3, 263-268.
DOI
|
| 26 |
Asp, M. L., Tian, M., Wendel, A. A. and Belury, M. A. 2010. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int. J. Cancer 126, 756-763.
DOI
|
| 27 |
Cai, D., Frantz, J. D., Tawa, Jr. N. E., Melendez, P. A., Oh, B. C., Lidov, H. G., Hasselgren, P. O., Frontera, W. R., Lee, J., Glass, D. J. and Shoelson, S. E. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285-298.
DOI
|
| 28 |
Day, E. A., Ford, R. J., Smith, B. K., Mohammadi-Shemirani, P., Morrow, M. R., Gutgesell, R. M., Lu, R., Raphenya, A. R., Kabiri, M., McArthur, A. G., McInnes, N., Hess, S., Pare, G., Gerstein, H. C. and Steinberg, G. R. 2019. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat. Metab. 1, 1202-1208.
DOI
|
| 29 |
Tsai, V. W., Lin, S., Brown, D. A., Salis, A. and Breit, S. N. 2016. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15. Int. J. Obes (Lond). 40, 193-197.
DOI
|
| 30 |
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., Wilding, J. P., Smith, D. M., Ghatei, M. A., Herbert, J. and Bloom, S. R. 1996. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72.
DOI
|
| 31 |
Argiles, J. M., Lopez-Soriano, J., Almendro, V., Busquets, S. and Lopez-Soriano, F. J. 2005. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med. Res. Rev. 25, 49-65.
DOI
|
| 32 |
Kwon, Y., Song, W., Droujinine, I. A., Hu, Y., Asara, J. M. and Perrimon, N. 2015. Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2. Dev. Cell 33, 36-46.
DOI
|
| 33 |
Evans, W. J., Morley, J. E., Argiles, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., Marks, D., Mitch, W. E., Muscaritoli, M., Najand, A., Ponikowski, P., Rossi Fanelli, F., Schambelan, M., Schols, A., Schuster, M., Thomas, D., Wolfe, R. and Anker, S. D. 2008. Cachexia: a new definition. Clin. Nutr. 27, 793-799.
DOI
|
| 34 |
Figueroa-Clarevega, A. and Bilder, D. 2015. Malignant drosophila tumors interrupt insulin signaling to induce cachexia-like wasting. Dev. Cell 33, 47-55.
DOI
|
| 35 |
Woods, S. C., Schwartz, M. W., Baskin, D. G. and Seeley, R. J. 2000. Food intake and the regulation of body weight. Annu. Rev. Psychol. 51, 255-277.
DOI
|
| 36 |
Argiles, J. M., Fontes-Oliveira, C. C., Toledo, M., Lopez-Soriano, F. J. and Busquets, S. 2014. Cachexia: a problem of energetic inefficiency. J. Cachexia Sarcopenia Muscle 5, 279-286.
DOI
|
| 37 |
Baltgalvis, K. A., Berger, F. G., Pena, M. M., Davis, J. M., Muga, S. J. and Carson, J. A. 2008. Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R393-401.
DOI
|
| 38 |
Bonaldo, P. and Sandri, M. 2013. Cellular and molecular mechanisms of muscle atrophy. Dis. Model. Mech. 6, 25-39.
DOI
|
| 39 |
Campos, C. A., Bowen, A. J., Han, S., Wisse, B. E., Palmiter, R. D. and Schwartz, M. W. 2017. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus. Nat. Neurosci. 20, 934-942.
DOI
|
| 40 |
Cohen, S., Nathan, J. A. and Goldberg, A. L. 2015. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat. Rev. Drug. Discov. 14, 58-74.
DOI
|
| 41 |
Laviano, A., Meguid, M. M., Yang, Z. J., Gleason, J. R., Cangiano, C. and Rossi Fanelli, F. 1996. Cracking the riddle of cancer anorexia. Nutrition 12, 706-710.
|
| 42 |
Martinez-Sanchez, N., Alvarez, C. V., Ferno, J., Nogueiras, R., Dieguez, C. and Lopez, M. 2014. Hypothalamic effects of thyroid hormones on metabolism. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 703-712.
DOI
|
| 43 |
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass Jr., H. O., Engstrom, P. F., Ezdinli, E. Z., Horton, J., Johnson, G. J., Moertel, C. G., Oken, M. M., Perlia, C., Rosenbaum, C., Silverstein, M. N., Skeel, R. T., Sponzo, R. W. and Tormey, D. C. 1980. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am. J. Med. 69, 491-497.
DOI
|
| 44 |
Engineer, D. R. and Garcia, J. M. 2012. Leptin in anorexia and cachexia syndrome. Int. J. Pept. 2012, 287457.
DOI
|
| 45 |
Ezeoke, C. C. and Morley, J. E. 2015. Pathophysiology of anorexia in the cancer cachexia syndrome. J. Cachexia Sarcopenia Muscle 6, 287-302.
DOI
|
| 46 |
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., Cone, R. D. and Low, M. J. 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484.
DOI
|
| 47 |
Powrozek, T., Mlak, R., Brzozowska, A., Mazurek, M., Golebiowski, P. and Malecka-Massalska, T. 2018. Relationship between TNF-alpha -1031T/C gene polymorphism, plasma level of TNF-alpha, and risk of cachexia in head and neck cancer patients. J. Cancer Res. Clin. Oncol. 144, 1423-1434.
DOI
|
| 48 |
Schwartz, M. W., Dallman, M. F. and Woods, S. C. 1995. Hypothalamic response to starvation: implications for the study of wasting disorders. Am. J. Physiol. 269, R949-957.
|
| 49 |
Imai, H., Soeda, H., Komine, K., Otsuka, K. and Shibata, H. 2013. Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliat. Care. 12, 38.
DOI
|
| 50 |
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., Hunter, M., Fairlie, W. D., Lee, N. J., Enriquez, R. F., Baldock, P. A., Corey, E., Apple, F. S., Murakami, M. M., Lin, E. J., Wang, C., During, M. J., Sainsbury, A., Herzog, H. and Breit, S. N. 2007. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat. Med. 13, 1333-1340.
DOI
|
| 51 |
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J. and Baskin, D. G. 2000. Central nervous system control of food intake. Nature 404, 661-671.
DOI
|
| 52 |
Suriben, R., Chen, M., Higbee, J., Oeffinger, J., Ventura, R., Li, B., Mondal, K., Gao, Z., Ayupova, D., Taskar, P., Li, D., Starck, S. R., Chen, H. H., McEntee, M., Katewa, S. D., Phung, V., Wang, M., Kekatpure, A., Lakshminarasimhan, D., White, A., Olland, A., Haldankar, R., Solloway, M. J., Hsu, J. Y., Wang, Y., Tang, J., Lindhout, D. A. and Allan, B. B. 2020. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat. Med. 26, 1264-1270.
DOI
|
| 53 |
Tisdale, M. J. 2002. Cachexia in cancer patients. Nat. Rev. Cancer 2, 862-871.
DOI
|
| 54 |
Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., Argiles, J. M., Baccino, F. M. and Rossi Fanelli, F. 2006. IGF-1 is downregulated in experimental cancer cachexia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R674-683.
DOI
|
| 55 |
Langhans, W. and Hrupka, B. 1999. Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33, 415-424.
DOI
|
| 56 |
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., Bissell, M. J., Cox, T. R., Giaccia, A. J., Erler, J. T., Hiratsuka, S., Ghajar, C. M. and Lyden, D. 2017. Premetastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302-317.
DOI
|
| 57 |
Penna, F., Bonetto, A., Muscaritoli, M., Costamagna, D., Minero, V. G., Bonelli, G., Rossi Fanelli, F., Baccino, F. M. and Costelli, P. 2010. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? Int. J. Cancer 127, 1706-1717.
DOI
|
| 58 |
Scheede-Bergdahl, C., Watt, H. L., Trutschnigg, B., Kilgour, R. D., Haggarty, A., Lucar, E. and Vigano, A. 2012. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin. Nutr. 31, 85-88.
DOI
|
| 59 |
Matthys, P. and Billiau, A. 1997. Cytokines and cachexia. Nutrition 13, 763-770.
DOI
|
| 60 |
Yeom, E., Shin, H., Yoo, W., Jun, E., Kim, S., Hong, S. H., Kwon, D. W., Ryu, T. H., Suh, J. M., Kim, S. C., Lee, K. S. and Yu, K. 2021. Tumour-derived Dilp8/INSL3 induces cancer anorexia by regulating feeding neuropeptides via Lgr3/8 in the brain. Nat. Cell. Biol. 23, 172-183.
DOI
|
| 61 |
Tazi, E. and Errihani, H. 2010. Treatment of cachexia in oncology. Indian J. Palliat. Care 16, 129-137.
DOI
|
| 62 |
Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A. and Ringold, G. M. 1985. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229, 867-869.
DOI
|
webmaster
